3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine

C84H80BBr4N17O2 — CID 161268415

IUPAC3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine
SMILESCc1c(Br)cncc1Br.Cc1cncc(-c2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)c1C.Cc1cncc(-c2ccc3c(c2)c(-c2nc4ccccc4[nH]2)nn3C)c1C.Cc1cncc(Br)c1C.Cc1cncc(Br)c1C.Cn1nc(-c2nc3ccccc3[nH]2)c2cc(B3OC(C)(C)C(C)(C)O3)ccc21
InChIInChI=1S/C22H19N5.C21H23BN4O2.C21H17N5.2C7H8BrN.C6H5Br2N/c1-13-11-23-12-17(14(13)2)15-8-9-20-16(10-15)21(26-27(20)3)22-24-18-6-4-5-7-19(18)25-22;1-20(2)21(3,4)28-22(27-20)13-10-11-17-14(12-13)18(25-26(17)5)19-23-15-8-6-7-9-16(15)24-19;1-12-10-22-11-16(13(12)2)14-7-8-17-15(9-14)20(26-25-17)21-23-18-5-3-4-6-19(18)24-21;2*1-5-3-9-4-7(8)6(5)2;1-4-5(7)2-9-3-6(4)8/h4-12H,1-3H3,(H,24,25);6-12H,1-5H3,(H,23,24);3-11H,1-2H3,(H,23,24)(H,25,26);2*3-4H,1-2H3;2-3H,1H3
InChIKeyVDMMKPWWBLDUOP-UHFFFAOYSA-N
MW1690.11 g/mol
LogP20.83
Rot. Bonds6

About 3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine

3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine (PubChem CID 161268415) has the molecular formula C84H80BBr4N17O2 and a molecular weight of 1690.11 g/mol. Its IUPAC name is 3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine.

Molecular Properties

Compound Name3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine
PubChem CID161268415
Molecular FormulaC84H80BBr4N17O2
Molecular Weight1690.11 g/mol
Exact Mass1685.35
IUPAC Name3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine
SMILESCc1c(Br)cncc1Br.Cc1cncc(-c2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)c1C.Cc1cncc(-c2ccc3c(c2)c(-c2nc4ccccc4[nH]2)nn3C)c1C.Cc1cncc(Br)c1C.Cc1cncc(Br)c1C.Cn1nc(-c2nc3ccccc3[nH]2)c2cc(B3OC(C)(C)C(C)(C)O3)ccc21
InChIInChI=1S/C22H19N5.C21H23BN4O2.C21H17N5.2C7H8BrN.C6H5Br2N/c1-13-11-23-12-17(14(13)2)15-8-9-20-16(10-15)21(26-27(20)3)22-24-18-6-4-5-7-19(18)25-22;1-20(2)21(3,4)28-22(27-20)13-10-11-17-14(12-13)18(25-26(17)5)19-23-15-8-6-7-9-16(15)24-19;1-12-10-22-11-16(13(12)2)14-7-8-17-15(9-14)20(26-25-17)21-23-18-5-3-4-6-19(18)24-21;2*1-5-3-9-4-7(8)6(5)2;1-4-5(7)2-9-3-6(4)8/h4-12H,1-3H3,(H,24,25);6-12H,1-5H3,(H,23,24);3-11H,1-2H3,(H,23,24)(H,25,26);2*3-4H,1-2H3;2-3H,1H3
InChIKeyVDMMKPWWBLDUOP-UHFFFAOYSA-N
XLogP20.83
TPSA233.27 Ų
H-Bond Donors4
H-Bond Acceptors15
Rotatable Bonds6
Heavy Atoms108
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001690.11
LogP ≤ 520.83
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine?
The IUPAC name of 3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine (CID 161268415) is 3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine.
What is the SMILES notation for 3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine?
The canonical SMILES for 3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine is Cc1c(Br)cncc1Br.Cc1cncc(-c2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)c1C.Cc1cncc(-c2ccc3c(c2)c(-c2nc4ccccc4[nH]2)nn3C)c1C.Cc1cncc(Br)c1C.Cc1cncc(Br)c1C.Cn1nc(-c2nc3ccccc3[nH]2)c2cc(B3OC(C)(C)C(C)(C)O3)ccc21.
What is the InChIKey of 3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine?
The InChIKey is VDMMKPWWBLDUOP-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H19N5.C21H23BN4O2.C21H17N5.2C7H8BrN.C6H5Br2N/c1-13-11-23-12-17(14(13)2)15-8-9-20-16(10-15)21(26-27(20)3)22-24-18-6-4-5-7-19(18)25-22;1-20(2)21(3,4)28-22(27-20)13-10-11-17-14(12-13)18(25-26(17)5)19-23-15-8-6-7-9-16(15)24-19;1-12-10-22-11-16(13(12)2)14-7-8-17-15(9-14)20(26-25-17)21-23-18-5-3-4-6-19(18)24-21;2*1-5-3-9-4-7(8)6(5)2;1-4-5(7)2-9-3-6(4)8/h4-12H,1-3H3,(H,24,25);6-12H,1-5H3,(H,23,24);3-11H,1-2H3,(H,23,24)(H,25,26);2*3-4H,1-2H3;2-3H,1H3.
What are the key properties of 3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine?
3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine has a molecular weight of 1690.11 g/mol, XLogP of 20.83, 6 rotatable bonds, 4 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-5-(4,5-dimethyl-3-pyridinyl)-1-methylindazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4,5-dimethylpyridine);3,5-dibromo-4-methylpyridine is sourced from PubChem (CID 161268415), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).